Gestational trophoblastic tumors Gestationsbedingte Trophoblasttumoren
Mundhenke C (2017)
Publication Type: Journal article, Review article
Publication year: 2017
Journal
Book Volume: 50
Pages Range: 860-866
Journal Issue: 11
DOI: 10.1007/s00129-017-4138-8
Abstract
Gestational trophoblastic disease includes a group of rare pregnancy-related tumors, consisting of premalignant lesions of complete and partial hydatidiform moles and the malignant tumors of invasive moles, choriocarcinoma and the rare placental site trophoblastic tumor. With improved diagnosis and therapy the overall survival rate now exceeds 98% whereas 60 years ago most women would have died from the malignant forms of the disease. This success can be explained by the development of effective forms of treatment, the use of human chorionic gonadotropin as a biomarker and centralization of oncological care. Therapy approaches for gestational trophoblastic disease are addressed and appropriate follow-up measures are discussed.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Mundhenke, C. (2017). Gestational trophoblastic tumors Gestationsbedingte Trophoblasttumoren. Gynäkologe, 50(11), 860-866. https://doi.org/10.1007/s00129-017-4138-8
MLA:
Mundhenke, Christoph. "Gestational trophoblastic tumors Gestationsbedingte Trophoblasttumoren." Gynäkologe 50.11 (2017): 860-866.
BibTeX: Download